Tenax Therapeutics's ticker is and the CUSIP is 88032L506. A total of 16 filers reported holding Tenax Therapeutics in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,969 | – | 16,564 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Allworth Financial LP | 1 | $1 | 0.00% |
| WELLS FARGO & COMPANY/MN | 158 | $47 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Horan Securities, Inc. | 1 | $0 | 0.00% |
| Banque Cantonale Vaudoise | 50 | $0 | 0.00% |
| TUCKER ASSET MANAGEMENT LLC | 2 | $1 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 16,564 | $4,969 | 0.00% |
| BlackRock Finance, Inc. | 23,922 | $7,177 | 0.00% |
| LPL Financial LLC | 20,000 | $6,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 19,764 | $5,929 | 0.00% |